Abstract
Cyanobacteria are ubiquitous photosynthetic prokaryotic organisms, which can form blooms and scums in surface water, characterized by a wide morphological variability. Different cyanobacteria strains, i.e., Microcystis, Planktothrix and Anabaena spp., produce microcystins (MCs), a group of more than 100 different structural variants of toxic cyclic heptapeptides, with a common cyanobacteria-specific amino acid, Adda. MC variants differ from each other for amino acid substitutions in positions 2 and 4 (where MC-LR has leucine (L) and arginine (R), respectively) and other changes. Humans may be exposed to MCs through the oral route, by ingestion of contaminated drinking water or food (including dietary supplements) or water during recreational activities. Dermal/inhalation and parenteral exposure may also occur, the latter due to the use of contaminated water for hemodialysis, leading to fatal outcome. The acute hepatotoxicity is congener specific (range of intraperitoneal LD50 in mice: 50–1200 μg/kg body weight). Renal and neurotoxic effects have also been reported for some variants. Minimal structural changes among variants result in three- to fourfold differences in MC toxicokinetics: the active uptake and the biotransformation have been shown to be congener dependent. MC-LR mechanism of action is associated with inhibition of protein serine/threonine phosphatases (PP1 and PP2A): the altered phosphorylation of cellular proteins involved in signal transduction leads to cascade of events (lipid peroxidation, oxidative stress, apoptosis). MC-LR has been shown to be not mutagenic but has tumor-promoting activity; on this basis, IARC classified it as a 2B carcinogen. The WHO has defined a guidance value for drinking water of 1 μg MCs/L.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Azevedo SM, Jochimsen EM, Rinehart KL, Lau S, Shaw GR, Eaglesham GK. Human intoxication by microcystins during renal dialysis treatment in Caruaru-Brazil. Toxicology. 2002;181:441–6.
Babior BM. Phagocytes and oxidative stress. Am J Med. 2000;109:33–44.
Berry J. Cyanobacterial toxins in food-webs: implications for human and environmental health. Curr Top Public Health. 2013;24:536–89.
Buratti FM, Scardala S, Funari E, Testai E. Glutathione transferases catalyzing the conjugation of the hepatoxin microcystin-LR. Chem Res Toxicol. 2011;24:926–33.
Buratti FM, Scardala S, Funari E, Testai E. The conjugation of microcystin-RR by human recombinant GSTs and hepatic cytosol. Toxicol Lett. 2013;219:231–8.
Campos A, Vasconcelos V. Molecular mechanisms of microcystin toxicity in animal cells. Int J Mol Sci. 2010;11(1):268–87.
Carmichael WW, Mahmood NA, Hyde EG. Natural toxins from cyanobacteria (blue-green algae). In: Hall S, Strichartz G, editors. Marine toxins: origins, structure and molecular pharmacology. Washington, DC: American Chemical Society; 1990. p. 87–106.
Chen J, Xie P, Li L, Xu J. First identification of the hepatotoxic microcystins in the serum of a chronically exposed human population together with indication of hepatocellular damage. Toxicol Sci. 2009;108:81–9.
Chorus L, Bartram J. Toxic cyanobacteria in water. Published on behalf of WHO by E&FN Spon, London/New York; 1999.
Craig M, Luu H A, McCready TL, Williams D, Andersen RJ, Holmes CF. Molecular mechanisms underlying he interaction of motuporin and microcystins with type-1 and type-2A protein phosphatases. Biochem Cell Biol. 1996;74(4):569–78.
Dietrich D, Hoeger S. Guidance values for microcystins in water and cyanobacterial supplement products (blue green algal supplements): a reasonable or misguided approach? Toxicol Appl Pharmacol. 2005;203:273–89.
Falconer IR.Is there a human health hazard from microcystins in the drinking water supply? Acta Hydrochimica Et Hydrobiologica. 2005;33(1):64–71.
Fawell JK. Toxins from blue-green algae: toxicological assessment of microcystin-LR. Microcystin-LR: 13 week oral (gavage) toxicity study in the mouse. Final report, vol. 4. Medmenham: Water Research Center; 1993. p. 1–259.
Feurstein D, Holst K, Fischer A, Dietrich DR. Oatp-associated uptake and toxicity of microcystins in primary murine whole brain cells. Toxicol Appl Pharmacol. 2009;234:247–55.
Feurstein D, Stemmer K, Kleinteich J, Speicher T, Dietrich DR. Microcystin congener- and concentration-dependent induction of murine neuron apoptosis and neurite degeneration. Toxicol Sci. 2011;124(2):424–31.
Fischer A, Hoeger SJ, Stemmer K, Feurstein DJ, Knobeloch D, Nussler A, et al. The role of organic anion transporting polypeptides (OATPs/SLCOs) in the toxicity of different microcystin congeners in vitro: a comparison of primary human hepatocytes and OATP-transfected HEK293 cells. Toxicol Appl Pharmacol. 2010;245:9–20.
Fromme H, Kohler A, Fuehrling D. Occurrence of cyanobacterial toxins – microcystins and anatoxin-a – in Berlin water bodies with implications to human health and regulation. Environ Toxicol. 2000;15:120–30.
Funari E, Testai E. Human health risk assessment related to cyanotoxins exposure. Crit Rev Toxicol. 2008;38:97–125.
Gehringer MM. Microcystin-LR and okadaic acid-induced cellular effects: a dualistic response. FEBS Lett. 2004;557:1–8.
Giannuzzi L, Sedan D, Echenique R, Andrinolo D. An acute case of intoxication with cyanobacteria and cyanotoxins in recreational water in Salto Grande Dam, Argentina. Mar Drugs. 2011;9:2164–75.
Harada K, Imanishi S, Kato H, Mizuno M, Ito E, Tsuji K. Isolation of ADDA from microcystin-LR by microbial degradation. Toxicon. 2004;44:107–9.
Hilborn ED, Carmichael WW, Soares RM, Yuan M, Servaites JC, Barton HA, et al. Serologic evaluation of human microcystin exposure. Environ Toxicol. 2007;22(5):459–63.
Hilborn ED, Roberts VA, Backer L, Deconno E, Egan JS, Hyde JB, et al. Algal bloom-associated disease outbreaks among users of freshwater lakes – United States, 2009–2010. Centers for Disease Control and Prevention (CDC), editor. MMWR Morb Mortal Wkly Rep. 2014;63(1):11–5.
IARC MONOGRAPHS. Cyanobacterial peptide toxins. 2006;94.
Ito E, Kondo F, Terao K, Harada K-I. Neoplastic nodular formation in mouse liver induced by repeated intraperitoneal injections of microcystin-LR. Toxicon. 1997;35:1453–7.
Ito E, Takai A, Kondo F, Masui I, Imanishi S, Harada K. Comparison of protein phosphatase inhibitory activity and apparent toxicity of microcystins and related compounds. Toxicon. 2002;40(7):1017–25.
Kujbida P, Hatanaka E, Vinolo MA, Waismam K, Cavalcanti DM, Curi R, et al. Microcystins -LA, -YR, and -LR action on neutrophil migration. Biochem Biophys Res Commun. 2009;382:9–14.
Kurmayer R, Dittmann E, Fastner J, Chorus I. Diversity of microcystin genes within a population of the toxic cyanobacterium Mycrocystis spp. in lake Wannsee (Berlin, Germany). Microb Ecol. 2002;43:107–18.
Li Y, Chen J, Zhao Q, Pu C, Qiu Z, Zhang R, et al. A cross-sectional investigation of chronic exposure to microcystin in relationship to childhood liver damage in the Three Gorges Reservoir Region, China. Environ Health Perspect. 2011;119:1483–8.
Lowe J, Souza-Menezes J, Freire DS, Mattos LJ, Castiglione RC, Barbosa CM, et al. Single sublethal dose of microcystin-LR is responsible for different alterations in biochemical, histological and physiological renal parameters. Toxicon. 2012;59(6):601–9.
Lu H, Choudhuri S, Ogura K, Csanaky IL, Lei X, Cheng X, et al. Characterization of organic anion transporting polypeptide 1b2-null mice: essential role in hepatic uptake/toxicity of phalloidin and microcystin-LR. Toxicol Sci. 2008;103:35–45.
MacKintosh C, Beattie KA, Klumpp S, Cohen P, Codd GA. Cyanobacterial microcystin-LR is a potent and specific inhibitor of protein phosphatases 1 and 2A from both mammals and higher plants. FEBS Lett. 1990;264:187–92.
Manganelli M, Scardala S, Stefanelli M, Vichi S, Mattei D, Bogialli S, et al. Health risk evaluation associated to Planktothrix rubescens: an integrated approach to design tailored monitoring programs for human exposure to cyanotoxins. Water Res. 2010;44:1297–306.
Manganelli M, Scardala S, Stefanelli M, Palazzo F, Funari E, Vichi S, et al. Emerging health issues of cyanobacterial blooms. Ann Ist Super Sanita. 2012;48(4):415–28.
Mbedi S, Welker M, Fastner J, Wiedner C. Variability of the microcystin synthetase gene cluster in the genus Planktothrix (Oscillatoriales, Cyanobacteria). FEMS Microbiol Lett. 2005;245(2):299–306.
Milutinović A, Zivin M, Zore-Pleskovic R, Sedmak B, Suput D. Nephrotoxic effects of chronic administration of microcystins-LR and -YR. Toxicon. 2003;42(3):281–8.
Nishiwaki R, Ohta T, Sueoka E, Suganuma M, Harada K-I, Watanabe MF, et al. Two significant aspects of microcystin-LR: specific binding and liver specificity. Cancer Lett. 1994;83:283–9.
Pearson LA, Moffitt MC, Ginn HP, Neilan BA. The molecular genetics and regulation of cyanobacterial peptide hepatotoxin biosynthesis. Crit Rev Toxicol. 2008;38:847–56.
Rantala A. Evolution and detection of cyanobacterial hepatotoxin synthetase genes. In: University of Helsinki, editor. Dissertationes bioscientiarum molecularium Universitatis Helsingiensis in Viikki, University of Helsinki. 2007.
Robinson NA, Pace JG, Matson CF, Miura GA, Lawrence WB. Tissue distribution, excretion and hepatic biotransformation of microcystin-LR in mice. J Pharmacol Exp Ther. 1991a;256:176–82.
Robinson NA, Matson CF, Pace JG. Association of microcystin-LR and its biotransformation product with a hepatic-cytosolic protein. J Biochem Toxicol. 1991b;6(3):171–80.
Schaeffer DJ, Malpas PB, Barton LL. Risk assessment of microcystin in dietary Aphanizomenon flos-aquae. Ecotoxicol Environ Saf. 1999;44:73–80.
Stewart I, Webb PM, Schluter PJ, Fleming LE, Burns JW, Gantar M, et al. Epidemiology of recreational exposure to freshwater cyanobacteria- an international prospective cohort study. BMC Public Health. 2006;6:93.
Stipa G, Taiuti R, de Scisciolo G, Arnetoli G, Tredici MR, Biondi N, et al. Sporadic amyotrophic lateral sclerosis as an infectious disease: a possible role of cyanobacteria? Med Hypotheses. 2006;67(6):1363–71.
Svircev Z, Drobac D, Tokodi N, Vidovic M, Simeunovic J, Miladinov-Mikov M, et al. Epidemiology of primary liver cancer in Serbia and possible connection with cyanobacterial blooms. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2013;31:181–200.
Vesterkvist PSM, Misiorek JO, Spoof LEM, Toivola DM, Meriluoto JAO. Comparative cellular toxicity of hydrophilic and hydrophobic microcystins on Caco-2 cells. Toxins. 2012;4:1008–23.
Vichi S, Lavorini P, Funari E, Scardala S, Testai E. Contamination by Microcystis and microcystins of blue-green algae food supplements (BGAS) on the Italian market and possible risk for the exposed population. Food Chem Toxicol. 2012;50(12):4493–9.
WHO. Guidelines for safe recreational water environment. Coastal and fresh waters. 1. Geneva: World Health Organization; 2003.
WHO. Guidelines for drinking-water quality, vol. 1. 3rd ed. Geneve: World Health Oragnizatione; 2004.
Young FM, Thomson C, Metcalf JS, Lucocq JM, Codd GA. Immunogold localisation of microcystins in cryosectioned cells of Microcystis. J Struct Biol. 2005;151:208–14.
Žegura B, Štraser A, Filipic M. Genotoxicity and potential carcinogenicity of cyanobacterial toxins: a review. Mutat Res. 2011;727:16–41.
Zurawell RW, Chen H, Burke JM, Prepas EE. Hepatotoxic cyanobacteria: a review of the biological importance of microcystins in freshwater environments. J Toxicol Environ Health Part B. 2005;8:1–37.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media Dordrecht
About this entry
Cite this entry
Vichi, S., Buratti, F.M., Testai, E. (2016). Microcystins: Toxicological Profile. In: Gopalakrishnakone, P., Haddad Jr., V., Tubaro, A., Kim, E., Kem, W. (eds) Marine and Freshwater Toxins. Toxinology. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6419-4_24
Download citation
DOI: https://doi.org/10.1007/978-94-007-6419-4_24
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6418-7
Online ISBN: 978-94-007-6419-4
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences